Harold Selick, Director at Molecular Templates, holds 28.00K shares in Protagonist Therapeutics (Ticker: PTGX), holds 256.83K shares in PDL BioPharma (Ticker: PDLI), holds 32.85K shares in Gyre Therapeutics (Ticker: GYRE). Most recently, Harold Selick Bought ― shares of Protagonist Therapeutics on Mar 11, 2024 for an estimated value of 12.27K.